Effect Of Nalbuphine as adjuvant in epidural block
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037198
- Lead Sponsor
- Srishti Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
ASA I & II
ALL PATIENTS SCHEDULED FOR LOWER LIMB SURGERIES
Exclusion Criteria
1.patients refusal for the procedure
2.ASA grade III & IV
3.patient with known hypersensitivity to study drug
4.patients with difficulty in communication
5.patients with severe systemic disease like respiratory, cardiac, hpatic, renal disease
6.patient with neurological, psychiatric or neurovacular disorders
7. patients with any contraindication for regional anesthesia like bleeding disorders raised intracranial tension
8. history of spine surgery and spinal deformity
9.pregnant and lactating patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain Score (Visual analogue score)Timepoint: more than 5 (1-10 normal range)
- Secondary Outcome Measures
Name Time Method side effects if anyTimepoint: Introperatively, 24 hours and 48 hours postoperatively;duration of analgesiaTimepoint: 48 hours post operatively;Requirement of rescue analgesicTimepoint: Introperatively, 24 hours and 48 hours postoperatively